Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study in Adults With Desmoid Tumors

This is an open-label, multicenter, single-arm phase 2 clinical study designed to evaluate the efficacy, safety, tolerability, patient-reported outcomes (PROs), pharmacokinetics (PK), anti-drug antibody (ADA) and pharmacodynamics (PD) of ES014 in adult desmoid tumor patients.

Participants needed: 50
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Elpiscience (Suzhou) Biopharma, Ltd.Updated: Apr 30, 2026Locations: 1
Eligibility criteria

1) Histologically confirmed desmoid tumor. [+7]

1)Any prior therapy targeting CD39, CD73, adenosine A2A receptor, or TGF-β. [+8]

Status: Recruiting

A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer

The aim of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics (PK) and immunogenicity of ES102 in combination with Toripalimab in subjects with advanced non-small cell lung cancer (NSCLC).

Participants needed: 40
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Elpiscience (Suzhou) Biopharma, Ltd.Updated: Sep 26, 2025Locations: 9
Eligibility criteria

Having sufficient understanding of this study and being willing to sign the info... [+11]

Any prior therapy targeting OX40. [+25]